{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:28:09Z","timestamp":1770838089888,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"DOI":"10.1186\/s13040-025-00472-7","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T14:23:47Z","timestamp":1755440627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the common genetic basis of metabolic syndrome-related diseases and chronic kidney disease: insights from extensive genome-wide cross-trait analyses"],"prefix":"10.1186","volume":"18","author":[{"given":"Yu","family":"Yin","sequence":"first","affiliation":[]},{"given":"Chenkai","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Yibo","family":"Hua","sequence":"additional","affiliation":[]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Dandan","family":"Qiu","sequence":"additional","affiliation":[]},{"given":"Jiasheng","family":"Yan","sequence":"additional","affiliation":[]},{"given":"Xiaodong","family":"Jin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"issue":"7","key":"472_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2337\/dc17-2629","volume":"41","author":"S Rawal","year":"2018","unstructured":"Rawal S, et al. Gestational diabetes mellitus and renal function: A prospective study with 9- to 16-Year Follow-up after pregnancy. Diabetes Care. 2018;41(7):1378\u201384.","journal-title":"Diabetes Care"},{"key":"472_CR2","doi-asserted-by":"publisher","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","volume":"3","author":"P Romagnani","year":"2017","unstructured":"Romagnani P, et al. Chronic kidney disease. Nat Rev Dis Primers. 2017;3:17088.","journal-title":"Nat Rev Dis Primers"},{"key":"472_CR3","doi-asserted-by":"crossref","unstructured":"Bello AK et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl (2011), 2017;7(2):122\u20139.","DOI":"10.1016\/j.kisu.2017.07.007"},{"issue":"1","key":"472_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5853\/jos.2015.17.1.31","volume":"17","author":"K Toyoda","year":"2015","unstructured":"Toyoda K. Cerebral small vessel disease and chronic kidney disease. J Stroke. 2015;17(1):31\u20137.","journal-title":"J Stroke"},{"key":"472_CR5","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333.","DOI":"10.1016\/S0140-6736(19)32977-0"},{"issue":"4","key":"472_CR6","doi-asserted-by":"publisher","first-page":"e13945","DOI":"10.1111\/eci.13945","volume":"53","author":"SM Fanaei","year":"2023","unstructured":"Fanaei SM, et al. The impact of metabolic syndrome on chronic kidney disease development. Insights from a big prospective study. Eur J Clin Invest. 2023;53(4):e13945.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"472_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-019-1121-5","volume":"18","author":"K Xie","year":"2019","unstructured":"Xie K, et al. The association of metabolic syndrome components and chronic kidney disease in patients with hypertension. Lipids Health Dis. 2019;18(1):229.","journal-title":"Lipids Health Dis"},{"key":"472_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.trsl.2016.12.004","volume":"183","author":"X Zhang","year":"2017","unstructured":"Zhang X, Lerman LO. The metabolic syndrome and chronic kidney disease. Transl Res. 2017;183:14\u201325.","journal-title":"Transl Res"},{"issue":"11","key":"472_CR9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2215\/CJN.11971018","volume":"14","author":"X Chen","year":"2019","unstructured":"Chen X, et al. Genetic and environmental influences on the correlations between traits of metabolic syndrome and CKD. Clin J Am Soc Nephrol. 2019;14(11):1590\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"472_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41588-020-0653-y","volume":"52","author":"Z Ning","year":"2020","unstructured":"Ning Z, Pawitan Y, Shen X. High-definition likelihood inference of genetic correlations across human complex traits. Nat Genet. 2020;52(8):859\u201364.","journal-title":"Nat Genet"},{"issue":"3","key":"472_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"BK Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan BK, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47(3):291\u20135.","journal-title":"Nat Genet"},{"issue":"1","key":"472_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12916-024-03385-0","volume":"22","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis. BMC Med. 2024;22(1):161.","journal-title":"BMC Med"},{"issue":"4","key":"472_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamapsychiatry.2022.4974","volume":"80","author":"W Gong","year":"2023","unstructured":"Gong W, et al. Role of the Gut-Brain axis in the shared genetic etiology between Gastrointestinal tract diseases and psychiatric disorders: A Genome-Wide pleiotropic analysis. JAMA Psychiatry. 2023;80(4):360\u201370.","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"472_CR14","doi-asserted-by":"publisher","first-page":"e1009218","DOI":"10.1371\/journal.pgen.1009218","volume":"16","author":"D Ray","year":"2020","unstructured":"Ray D, Chatterjee N. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between type 2 diabetes and prostate cancer. PLoS Genet. 2020;16(12):e1009218.","journal-title":"PLoS Genet"},{"issue":"7319","key":"472_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"GR Abecasis","year":"2010","unstructured":"Abecasis GR, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061\u201373.","journal-title":"Nature"},{"key":"472_CR16","doi-asserted-by":"publisher","unstructured":"The GTEx Consortium ,The GTEx Consortium atlas of genetic regulatory effects across human tissues.Science369,1318-1330(2020).DOI:10.1126\/science.aaz1776The GTEx consortium atlas of genetic regulatory effects across human tissues. Science, 2020;369(6509):1318\u201330. https:\/\/doi.org\/10.1126\/science.aaz1776","DOI":"10.1126\/science.aaz1776"},{"issue":"43","key":"472_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"472_CR18","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, et al. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826.","journal-title":"Nat Commun"},{"issue":"1","key":"472_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","volume":"12","author":"CN Foley","year":"2021","unstructured":"Foley CN, et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nat Commun. 2021;12(1):764.","journal-title":"Nat Commun"},{"issue":"4","key":"472_CR20","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, et al. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11(4):e1004219.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"472_CR21","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734\u20139.","journal-title":"Int J Epidemiol"},{"key":"472_CR22","doi-asserted-by":"crossref","unstructured":"Zhao Q et al. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. 2020.","DOI":"10.1214\/19-AOS1866"},{"issue":"7","key":"472_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/0003-4819-148-7-200804010-00006","volume":"148","author":"B Kestenbaum","year":"2008","unstructured":"Kestenbaum B, et al. Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med. 2008;148(7):501\u20138.","journal-title":"Ann Intern Med"},{"key":"472_CR24","doi-asserted-by":"crossref","unstructured":"Schnetzer L et al. Type 2 diabetes and chronic kidney disease as long-term predictors of cardiovascular events in patients with coronary artery disease. Eur J Clin Invest. 2024:e14374.","DOI":"10.1111\/eci.14374"},{"issue":"3","key":"472_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00125-010-1965-8","volume":"54","author":"GA Nichols","year":"2011","unstructured":"Nichols GA, Moler EJ. Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes. Diabetologia. 2011;54(3):523\u20136.","journal-title":"Diabetologia"},{"issue":"1","key":"472_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.23876\/j.krcp.21.099","volume":"41","author":"H Lee","year":"2022","unstructured":"Lee H, et al. Association between blood pressure and the risk of chronic kidney disease in treatment-na\u00efve hypertensive patients. Kidney Res Clin Pract. 2022;41(1):31\u201342.","journal-title":"Kidney Res Clin Pract"},{"issue":"6","key":"472_CR27","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","volume":"71","author":"K Umanath","year":"2018","unstructured":"Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884\u201395.","journal-title":"Am J Kidney Dis"},{"key":"472_CR28","doi-asserted-by":"crossref","unstructured":"Rapa SF et al. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019;21(1).","DOI":"10.3390\/ijms21010263"},{"issue":"6","key":"472_CR29","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1161\/STROKEAHA.124.046249","volume":"55","author":"SC Larsson","year":"2024","unstructured":"Larsson SC, et al. Risk factors for intracerebral hemorrhage: Genome-Wide association study and Mendelian randomization analyses. Stroke. 2024;55(6):1582\u201391.","journal-title":"Stroke"},{"issue":"1","key":"472_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12944-020-01307-6","volume":"19","author":"J Shi","year":"2020","unstructured":"Shi J, et al. \u03b52 allele and \u03b52-involved genotypes (\u03b52\/\u03b52, \u03b52\/\u03b53, and \u03b52\/\u03b54) May confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis. Lipids Health Dis. 2020;19(1):136.","journal-title":"Lipids Health Dis"},{"key":"472_CR31","doi-asserted-by":"publisher","first-page":"144011","DOI":"10.1016\/j.gene.2019.144011","volume":"715","author":"KK Atageldiyeva","year":"2019","unstructured":"Atageldiyeva KK, et al. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients. Gene. 2019;715:144011.","journal-title":"Gene"},{"key":"472_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-016-0329-1","volume":"15","author":"D El-Lebedy","year":"2016","unstructured":"El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2016;15:12.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"472_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.metabol.2013.12.008","volume":"63","author":"YW Yin","year":"2014","unstructured":"Yin YW, et al. Influence of Apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies. Metabolism. 2014;63(4):532\u201341.","journal-title":"Metabolism"},{"issue":"5","key":"472_CR34","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","volume":"31","author":"D Baitsch","year":"2011","unstructured":"Baitsch D, et al. Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol. 2011;31(5):1160\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"472_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-019-1003-x","volume":"18","author":"M Czapli\u0144ska","year":"2019","unstructured":"Czapli\u0144ska M, et al. Apolipoprotein E gene polymorphism and renal function are associated with Apolipoprotein E concentration in patients with chronic kidney disease. Lipids Health Dis. 2019;18(1):60.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"472_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2337\/db14-0554","volume":"64","author":"L Shen","year":"2015","unstructured":"Shen L, et al. B-1a lymphocytes attenuate insulin resistance. Diabetes. 2015;64(2):593\u2013603.","journal-title":"Diabetes"},{"issue":"4","key":"472_CR37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/ATVBAHA.116.307166","volume":"36","author":"DB Harmon","year":"2016","unstructured":"Harmon DB, et al. Protective role for B-1b B cells and IgM in Obesity-Associated inflammation, glucose intolerance, and insulin resistance. Arterioscler Thromb Vasc Biol. 2016;36(4):682\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"472_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fphys.2017.00719","volume":"8","author":"P Srikakulapu","year":"2017","unstructured":"Srikakulapu P, et al. Perivascular adipose tissue harbors atheroprotective IgM-Producing B cells. Front Physiol. 2017;8:719.","journal-title":"Front Physiol"},{"key":"472_CR39","doi-asserted-by":"publisher","first-page":"636013","DOI":"10.3389\/fimmu.2021.636013","volume":"12","author":"P Srikakulapu","year":"2021","unstructured":"Srikakulapu P, et al. Chemokine Receptor-6 promotes B-1 cell trafficking to perivascular adipose tissue, local IgM production and atheroprotection. Front Immunol. 2021;12:636013.","journal-title":"Front Immunol"},{"issue":"6","key":"472_CR40","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1681\/ASN.2014010127","volume":"25","author":"C Westenfelder","year":"2014","unstructured":"Westenfelder C. Does the greater omentum (policeman of the abdomen) possess therapeutic utility in CKD? J Am Soc Nephrol. 2014;25(6):1133\u20135.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"472_CR41","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1681\/ASN.2013040387","volume":"25","author":"I Garcia-Gomez","year":"2014","unstructured":"Garcia-Gomez I, et al. Activated omentum slows progression of CKD. J Am Soc Nephrol. 2014;25(6):1270\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"472_CR42","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/0735-1097(94)90182-1","volume":"24","author":"H Sawa","year":"1994","unstructured":"Sawa H, et al. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis. J Am Coll Cardiol. 1994;24(7):1742\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"472_CR43","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.ATV.0000227514.50065.2a","volume":"26","author":"Y Chen","year":"2006","unstructured":"Chen Y, et al. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol. 2006;26(8):1777\u201383.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"472_CR44","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12964-024-01873-7","volume":"22","author":"XX Zhu","year":"2024","unstructured":"Zhu XX, et al. Nesfatin-1 enhances vascular smooth muscle calcification through facilitating BMP-2 osteogenic signaling. Cell Commun Signal. 2024;22(1):488.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"472_CR45","doi-asserted-by":"publisher","first-page":"H1075","DOI":"10.1152\/ajpheart.00913.2007","volume":"294","author":"P Rose","year":"2008","unstructured":"Rose P, et al. Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, junb, and CREB. Am J Physiol Heart Circ Physiol. 2008;294(2):H1075\u201385.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"52","key":"472_CR46","doi-asserted-by":"publisher","first-page":"44646","DOI":"10.1074\/jbc.M111.265462","volume":"286","author":"Z Xie","year":"2011","unstructured":"Xie Z, et al. Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles. J Biol Chem. 2011;286(52):44646\u201358.","journal-title":"J Biol Chem"},{"issue":"5","key":"472_CR47","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41419-021-03709-5","volume":"12","author":"B Chen","year":"2021","unstructured":"Chen B, et al. Permissive effect of GSK3\u03b2 on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease. Cell Death Dis. 2021;12(5):432.","journal-title":"Cell Death Dis"},{"issue":"1","key":"472_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-023-01478-5","volume":"8","author":"C Huang","year":"2023","unstructured":"Huang C, et al. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis. Signal Transduct Target Ther. 2023;8(1):271.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"472_CR49","doi-asserted-by":"publisher","first-page":"15954","DOI":"10.1038\/s41598-020-72905-8","volume":"10","author":"L Estrada Mallarino","year":"2020","unstructured":"Estrada Mallarino L, et al. Nephronophthisis gene products display RNA-binding properties and are recruited to stress granules. Sci Rep. 2020;10(1):15954.","journal-title":"Sci Rep"},{"issue":"9","key":"472_CR50","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1681\/ASN.0000000000000170","volume":"34","author":"C Robinson-Cohen","year":"2023","unstructured":"Robinson-Cohen C, et al. Genome-Wide association study of CKD progression. J Am Soc Nephrol. 2023;34(9):1547\u201359.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"472_CR51","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","volume":"51","author":"M Wuttke","year":"2019","unstructured":"Wuttke M, et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet. 2019;51(6):957\u201372.","journal-title":"Nat Genet"},{"issue":"6","key":"472_CR52","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/JCI73072","volume":"124","author":"LD Mesner","year":"2014","unstructured":"Mesner LD, et al. Bicc1 is a genetic determinant of osteoblastogenesis and bone mineral density. J Clin Invest. 2014;124(6):2736\u201349.","journal-title":"J Clin Invest"},{"issue":"3","key":"472_CR53","doi-asserted-by":"publisher","first-page":"e88816","DOI":"10.1371\/journal.pone.0088816","volume":"9","author":"P Lian","year":"2014","unstructured":"Lian P, et al. Loss of polycystin-1 inhibits Bicc1 expression during mouse development. PLoS ONE. 2014;9(3):e88816.","journal-title":"PLoS ONE"},{"issue":"1","key":"472_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1242\/dev.133934","volume":"143","author":"LA Lemaire","year":"2016","unstructured":"Lemaire LA, et al. Bicaudal C1 promotes pancreatic NEUROG3\u2009+\u2009endocrine progenitor differentiation and ductal morphogenesis. Development. 2016;143(1):181.","journal-title":"Development"},{"issue":"6","key":"472_CR55","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/15548627.2019.1659613","volume":"16","author":"X Bai","year":"2020","unstructured":"Bai X, et al. CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis. Autophagy. 2020;16(6):1111\u201329.","journal-title":"Autophagy"},{"issue":"14","key":"472_CR56","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/cvr\/cvae102","volume":"120","author":"S Rawal","year":"2024","unstructured":"Rawal S, et al. miR-369-3p ameliorates diabetes-associated atherosclerosis by regulating macrophage succinate-GPR91 signalling. Cardiovasc Res. 2024;120(14):1693\u2013712.","journal-title":"Cardiovasc Res"},{"key":"472_CR57","unstructured":"Ibrahim S et al. Impact of cumulative LDL-C and other risk factors on CAD prevalence in patients with Familial hypercholesterolemia. Eur J Prev Cardiol. 2024."},{"issue":"12","key":"472_CR58","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1111\/dom.15956","volume":"26","author":"J Yachida","year":"2024","unstructured":"Yachida J, et al. Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses. Diabetes Obes Metab. 2024;26(12):5845\u201356.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"472_CR59","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12967-023-04509-5","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Understanding the relationship between Circulating lipids and risk of chronic kidney disease: a prospective cohort study and large-scale genetic analyses. J Transl Med. 2023;21(1):671.","journal-title":"J Transl Med"},{"issue":"10","key":"472_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/ckj\/sfac111","volume":"15","author":"A Osanami","year":"2022","unstructured":"Osanami A, et al. Increased LDL-cholesterol level is associated with deterioration of renal function in males. Clin Kidney J. 2022;15(10):1888\u201395.","journal-title":"Clin Kidney J"},{"issue":"3","key":"472_CR61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/pathophysiology29030029","volume":"29","author":"HH Nguyen","year":"2022","unstructured":"Nguyen HH, et al. TG\/HDL-C ratio is a risk factor associated with CKD: use in assessing the risk of progression of CKD. Pathophysiology. 2022;29(3):374\u201382.","journal-title":"Pathophysiology"},{"issue":"4","key":"472_CR62","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s11010-021-04061-0","volume":"476","author":"B Khwaja","year":"2021","unstructured":"Khwaja B, Thankam FG, Agrawal DK. Mitochondrial damps and altered mitochondrial dynamics in OxLDL burden in atherosclerosis. Mol Cell Biochem. 2021;476(4):1915\u201328.","journal-title":"Mol Cell Biochem"},{"issue":"7341","key":"472_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"issue":"17","key":"472_CR64","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575\u201384.","journal-title":"N Engl J Med"},{"issue":"5","key":"472_CR65","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.kint.2022.06.023","volume":"102","author":"W Zeng","year":"2022","unstructured":"Zeng W, et al. Lipidomic profiling in the strong heart study identified American Indians at risk of chronic kidney disease. Kidney Int. 2022;102(5):1154\u201366.","journal-title":"Kidney Int"},{"issue":"8","key":"472_CR66","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","volume":"117","author":"JE Hall","year":"2021","unstructured":"Hall JE, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859\u201376.","journal-title":"Cardiovasc Res"},{"issue":"3 Suppl 2","key":"472_CR67","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1053\/j.ajkd.2010.11.009","volume":"57","author":"SI McFarlane","year":"2011","unstructured":"McFarlane SI, et al. Comparison of the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the kidney early evaluation program (KEEP). Am J Kidney Dis. 2011;57(3 Suppl 2):S24\u201331.","journal-title":"Am J Kidney Dis"},{"key":"472_CR68","doi-asserted-by":"publisher","first-page":"111259","DOI":"10.1016\/j.mce.2021.111259","volume":"529","author":"F Rianto","year":"2021","unstructured":"Rianto F, et al. Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease. Mol Cell Endocrinol. 2021;529:111259.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"472_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","volume":"74","author":"E Ku","year":"2019","unstructured":"Ku E, et al. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74(1):120\u201331.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"472_CR70","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.ajkd.2018.02.362","volume":"72","author":"HR Yun","year":"2018","unstructured":"Yun HR, et al. Obesity, metabolic abnormality, and progression of CKD. Am J Kidney Dis. 2018;72(3):400\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"472_CR71","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/clinchem\/hvab249","volume":"68","author":"AD Kjaergaard","year":"2022","unstructured":"Kjaergaard AD, et al. Obesity and kidney function: A Two-Sample Mendelian randomization study. Clin Chem. 2022;68(3):461\u201372.","journal-title":"Clin Chem"},{"issue":"6","key":"472_CR72","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/ije\/dyab203","volume":"50","author":"J Zheng","year":"2022","unstructured":"Zheng J, et al. Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol. 2022;50(6):1995\u20132010.","journal-title":"Int J Epidemiol"}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-025-00472-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-025-00472-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-025-00472-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T05:08:05Z","timestamp":1757394485000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-025-00472-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1186\/s13040-025-00472-7","relation":{},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}